Atara Biotherap (ATRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 3,221 | 8,360 | 8,482 | 5,742 | 16,903 |
| Marketable Securities | 6,652 | N/A | N/A | 7,970 | 5,420 |
| Receivables | 318 | N/A | 1,253 | 1,913 | N/A |
| Other current assets | 3,339 | 3,813 | 2,477 | 2,807 | 2,449 |
| TOTAL | $13,530 | $12,173 | $12,212 | $18,432 | $24,772 |
| Non-Current Assets | |||||
| PPE Net | 41 | 55 | 73 | 147 | 176 |
| Other Non-Current Assets | 7,453 | 7,769 | 7,950 | 11,588 | 11,954 |
| TOTAL | $7,494 | $7,824 | $8,023 | $11,735 | $12,130 |
| Total Assets | $21,024 | $19,997 | $20,235 | $30,167 | $36,902 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 824 | 637 | 127 | 318 | 1,762 |
| Accrued Expenses | 699 | 629 | 1,271 | 2,067 | 2,552 |
| Other current liabilities | 4,492 | 3,654 | 12,726 | 14,319 | 7,671 |
| TOTAL | $6,847 | $5,645 | $14,922 | $18,057 | $14,563 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 775 | 684 | 716 | 1,011 | 1,607 |
| Other Non-Current Liabilities | 51,173 | 51,664 | 43,815 | 48,744 | 57,380 |
| TOTAL | $51,173 | $51,664 | $43,815 | $48,744 | $57,380 |
| Total Liabilities | $58,020 | $57,309 | $58,737 | $66,801 | $71,943 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 10,038 | 9,010 | 8,178 | 7,210 | 7,023 |
| Common Shares | 1 | 1 | 1 | 1 | 1 |
| Retained earnings | -2,030,844 | -2,026,010 | -2,021,865 | -2,018,459 | -2,014,156 |
| Other shareholders' equity | -2 | 0 | 1 | 2 | 0 |
| TOTAL | $-36,996 | $-37,312 | $-38,502 | $-36,634 | $-35,041 |
| Total Liabilities And Equity | $21,024 | $19,997 | $20,235 | $30,167 | $36,902 |